Clinical and Translational Medicine (Jul 2022)
The impact of ACE2 and co‐factors on SARS‐CoV‐2 infection in colorectal cancer
- Shuwei Li,
- Silu Chen,
- Qiuyuan Zhu,
- Shuai Ben,
- Fang Gao,
- Junyi Xin,
- Mulong Du,
- Haiyan Chu,
- Dongying Gu,
- Zhengdong Zhang,
- Meilin Wang
Affiliations
- Shuwei Li
- Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research The Affiliated Cancer Hospital of Nanjing Medical University Nanjing China
- Silu Chen
- Department of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine Nanjing Medical University Nanjing China
- Qiuyuan Zhu
- Department of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine Nanjing Medical University Nanjing China
- Shuai Ben
- Department of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine Nanjing Medical University Nanjing China
- Fang Gao
- Department of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine Nanjing Medical University Nanjing China
- Junyi Xin
- Department of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine Nanjing Medical University Nanjing China
- Mulong Du
- Department of Genetic Toxicology, The Key Laboratory of Modern Toxicology of Ministry of Education, Center for Global Health, School of Public Health Nanjing Medical University Nanjing China
- Haiyan Chu
- Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research The Affiliated Cancer Hospital of Nanjing Medical University Nanjing China
- Dongying Gu
- Department of Oncology Nanjing First Hospital Nanjing Medical University Nanjing China
- Zhengdong Zhang
- Department of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine Nanjing Medical University Nanjing China
- Meilin Wang
- Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research The Affiliated Cancer Hospital of Nanjing Medical University Nanjing China
- DOI
- https://doi.org/10.1002/ctm2.967
- Journal volume & issue
-
Vol. 12,
no. 7
pp. n/a – n/a
Abstract
No abstracts available.Keywords
